Holen Sie sich die Stockscreener-App
2.49
0.40%
-0.010
Handel nachbörslich:
2.54
0.05
+2.01%
Schlusskurs vom Vortag:
$2.50
Offen:
$2.49
24-Stunden-Volumen:
102.56K
Relative Volume:
0.40
Marktkapitalisierung:
$28.82M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-4.6981
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
+16.36%
1M Leistung:
+46.47%
6M Leistung:
+114.66%
1J Leistung:
+137.14%
1-Tages-Spanne:
$2.31
$2.5748
1-Wochen-Bereich:
$2.07
$2.59
52-Wochen-Spanne:
$0.72
$2.59
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Vergleichen Sie TXMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
2.49 | 28.94M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
125.08 | 54.31B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.08 | 51.02B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.11B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.41 | 35.98B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
469.77 | 20.15B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
Why TherapeuticsMD Inc. stock could rally in 2025Breakout Watch & High Conviction Investment Ideas - bollywoodhelpline.com
Momentum Shift: Is TherapeuticsMD Inc stock a falling knife or bargain buyGap Down & Weekly High Return Stock Opportunities - baoquankhu1.vn
Is TherapeuticsMD Inc forming a double bottomEarnings Trend Report & Reliable Trade Execution Plans - baoquankhu1.vn
Sell Signal: What is the fair value of TherapeuticsMD Inc stock nowMarket Performance Report & Verified Momentum Stock Watchlist - Bộ Nội Vụ
Gains Recap: Why retail investors pile into TherapeuticsMD Inc stockRate Hike & Daily Volume Surge Signals - Bộ Nội Vụ
Portfolio Shifts: Is TherapeuticsMD Inc stock heavily shortedMarket Sentiment Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Institution Moves: How strong is TherapeuticsMD Inc stock revenue growthJuly 2025 Outlook & Reliable Entry Point Alerts - Bộ Nội Vụ
TherapeuticsMD Reports Q3 2025 Financial Results - MSN
Why TherapeuticsMD Inc. stock could be next big winnerShare Buyback & Accurate Buy Signal Alerts - Улправда
Is TherapeuticsMD Inc. stock a buy for dividend growthCPI Data & Weekly Setup with ROI Potential - Улправда
Will TherapeuticsMD Inc. stock continue upward momentum2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда
Is TherapeuticsMD Inc. stock a safe haven asset2025 Performance Recap & Free Community Consensus Stock Picks - Улправда
Can TherapeuticsMD Inc. stock rebound after recent weaknessChart Signals & Smart Investment Allocation Tips - Улправда
Can TherapeuticsMD Inc. stock deliver strong Q4 earningsJuly 2025 EndofMonth & Community Trade Idea Sharing - Улправда
Chart Watch: Can TherapeuticsMD Inc. stock deliver strong Q4 earningsQuarterly Profit Report & Weekly Top Gainers Trade List - Улправда
How strong is TherapeuticsMD Inc. stock revenue growthTreasury Yields & Technical Pattern Recognition Alerts - Улправда
Analysis Recap: Why TherapeuticsMD Inc. stock could be next big winner2025 Key Lessons & Detailed Earnings Play Strategies - Улправда
Will TherapeuticsMD Inc. stock deliver long term returnsFibonacci Extensions & Easy Tools to Analyze Your Investment Risk - Улправда
EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire
Fund Flows: Why TherapeuticsMD Inc stock could be next big winnerMarket Sentiment Review & Stepwise Entry/Exit Trade Alerts - Bộ Nội Vụ
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD approves key proposals at annual meeting - MSN
TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why hedge funds are buying TherapeuticsMD Inc. stockWeekly Trade Report & Intraday High Probability Setup Alerts - Улправда
Rate Cut: Will TherapeuticsMD Inc. stock deliver long term returnsEarnings Overview Report & AI Powered Market Entry Strategies - Улправда
MSN Money - MSN
TherapeuticsMD Earnings Notes - Trefis
Block Trades: How currency fluctuations impact TherapeuticsMD Inc. stock2025 Momentum Check & Advanced Technical Analysis Signals - ulpravda.ru
How supply chain issues affect TherapeuticsMD Inc. stockJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Dilution adjustment of TherapeuticsMD, Inc. – FWB:29TA - TradingView — Track All Markets
TherapeuticsMD Approves Key Proposals at Annual Meeting - TipRanks
TherapeuticsMD (NASDAQ: TXMD) investors approve 2025 votes, 640M share authorization - Stock Titan
Price to earnings ratio of TherapeuticsMD, Inc. – DUS:29TA - TradingView — Track All Markets
29TA Stock Price and Chart — DUS:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Dip Buying: Is TherapeuticsMD Inc stock attractive for income investorsIPO Watch & AI Based Trade Execution Alerts - moha.gov.vn
With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis
TherapeuticsMD (TXMD) Stock Analysis Report | Financials & Insights - Benzinga
TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph
Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser
Will TherapeuticsMD Inc. (29TA) stock sustain bullish trend into 2025Trade Risk Summary & Safe Entry Zone Identification - Newser
Can TherapeuticsMD Inc. (29TA) stock test all time highsJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser
Is TherapeuticsMD Inc. stock affected by interest rate hikes - Newser
TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market - 富途牛牛
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
9.91%
2.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):